Sage Therapeutics Inc (NASDAQ: SAGE) is 38.12% higher on its value in year-to-date trading and has touched a low of $4.62 and a high of $28.26 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The SAGE stock was last observed hovering at around $5.55 in the last trading session, with the day’s gains setting it 1.95%.
Currently trading at $7.50, the stock is 32.30% and 32.78% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 12.06 million and changing 35.14% at the moment leaves the stock -19.58% off its SMA200. SAGE registered -70.47% loss for a year compared to 6-month loss of -36.22%. The firm has a 50-day simple moving average (SMA 50) of $5.668 and a 200-day simple moving average (SMA200) of $9.38165.
The stock witnessed a 34.65% gain in the last 1 month and extending the period to 3 months gives it a 17.74%, and is 22.15% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 6.93% over the week and 7.75% over the month.
Sage Therapeutics Inc (SAGE) has around 487 employees, a market worth around $458.80M and $106.40M in sales. Profit margin for the company is -317.29%. Distance from 52-week low is 62.34% and -73.46% from its 52-week high. The company has generated returns on investments over the last 12 months (-60.07%).
with sales reaching $14.11M over the same period.The EPS is expected to grow by 28.60% this year, but quarterly earnings will post -51.16% year-over-year. Quarterly sales are estimated to shrink -81.90% in year-over-year returns.
Sage Therapeutics Inc (SAGE) Top Institutional Holders
251.0 institutions hold shares in Sage Therapeutics Inc (SAGE), with institutional investors hold 98.09% of the company’s shares. The shares outstanding are 61.17M, and float is at 53.88M with Short Float at 8.97%. Institutions hold 86.40% of the Float.
The top institutional shareholder in the company is VANGUARD GROUP INC with over 6.42 million shares valued at $69.68 million. The investor’s holdings represent 10.6696% of the SAGE Shares outstanding. As of 2024-06-30, the second largest holder is FMR LLC with 5.82 million shares valued at $63.24 million to account for 9.6836 of the shares outstanding. The other top investors are RTW INVESTMENTS, LP which holds 5.48 million shares representing 9.1136% and valued at over $59.52 million, while BLACKROCK INC. holds 8.673 of the shares totaling 5.22 million with a market value of $56.64 million.
Sage Therapeutics Inc (SAGE) Insider Activity
#####
